A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus

Journal of Medical Virology

Volumn 60, Issue 4, 2000, Pages 446-454

  De Carvalho Nicacio, Cristina ^a,b   Lundkvist, Åke ^a,b   Brus Sjölander, Katarina ^a,b   Plyusnin, Alexander ^a,c   Salonen, Eeva Marjatta ^c   Björling, Ewa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

FRNT; G2 protein; Hantavirus; Phage display; Puumala virus; Recombinant Fab

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY COMBINING SITE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; NONHUMAN; PHAGE DISPLAY; PUUMALA VIRUS; SEQUENCE ANALYSIS; SPLEEN LYMPHOCYTE; VIRUS ENVELOPE; VIRUS PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HANTAVIRUS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; VERO CELLS; VIRAL ENVELOPE PROTEINS;

HANTAVIRUS; PUUMALA VIRUS; RNA VIRUSES;

EID: 0033997764     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200004)60:4<446::AID-JMV13>3.0.CO;2-V     Document Type: Article

References (44)

1. Antoniadis A, Stylianakis A, Papa A, Alexiou-Daniel S, Lampropoulos A, Nichol ST, Peters CJ, Spiropoulou CF. 1996. Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis 174:407-410.
2. Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS. 1989. Characterization of Hantaan virus envelope glycoprotein antigenie determinants defined by monoclonal antibodies. J Gen Virol 70:615-624.
3. Arikawa J, Yao JS, Yoshimatsu K, Takashima I, Hashimoto N. 1992. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch Virol 126:271-281.
4. Avsic-Zupanc T, Xiao SY, Stojanovic R, Gligic A, van der Groen G, LeDuc JW. 1992. Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia. J Med Virol 38:132-137.
5. Barbas CF III, Kang AS, Lerner RA, Benkovic SJ. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88:7978-7982.
6. Burton DR, Barbas CF III, Persson MAA, Koenig S, Chanock RM, Lerner RA. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 88:10134-10137.
7. Burton DR, Barbas CF III. 1994. Human antibodies from combinatorial libraries. Adv Immunol 57:191-280.
8. Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, Lamacchia M, Garratty E, Stiehm ER, Bryson YJ, Cao Y, Moore JP, Ho DD, Barbas CF III. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
9. Chu YK, Rossi C, Leduc JW, Lee HW, Schmaljohn CS, Dalrymple JM. 1994. Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology 198:196-204.
10. Crowe JE Jr., Murphy BR, Chanock RM, Williamson RA, Barbas CF III, Burton DR. 1994. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci USA 91:1386-1390.
11. Dimmock NJ. 1993. Neutralization of animal viruses. Curr Top Microbiol Immunol 183:1-149.
12. Enssle K, Kurrle R, Kohler R, Muller H, Kanzy EJ, Hilfenhaus J, Seiler FR. 1991. A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Hybridoma 10:547-556.
13. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. 1999. Cel-lular entry of Hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73:3951-3959.
14. Heiskanen T, Lundkvist Å, Vaheri A, Lankinen H. 1997. Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J Virol 71:3879-3885.
15. Hörling J, Cheng Y, Plyusnin A, Persson K, Lehvaslaiho H, Vaheri A, Niklasson B, Lundkvist Å. 1995. Nucleotide and deduced amino acid sequences of the M and S genome segments of a Swedish Puumala virus isolate. Virus Res 39:321-330.
16. Hörling J, Chizhikov V, Lundkvist Å, Jonsson M, Ivanov L, Dekonenko A, Niklasson B, Dzagurova T, Peters CJ, Tkachenko E, Nichol S. 1996. Khabarovsk virus: a phylogenetically and serologically distinct hantavirus isolated from Microtus fortis trapped in far-east Russia. J Gen Virol 77:687-694.
17. Hörling J, Lundkvist Å. 1997. Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes. Virus Res 48:89-100.
18. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. 1996. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 46:369-378.
19. Lee HW, Lee PW, Johnson KM. 1978. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 137:298-308.
20. Lee HW, Baek LJ, Johnson KM. 1982. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis 146:638-644.
21. Lee PW, Amyx HL, Gajdusek DC, Yanagihara RT, Goldgaber D, Gibbs CJ Jr. 1982. New hemorrhagic fever with renal syndrome-related virus in rodents in the United States. Lancet 2:1405.
22. Liang M, Guttieri M, Lundkvist Å, Schmaljohn C. 1997. Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus. Virology 235:252-260.
23. Lopez N, Padula P, Rossi C, Lazaro ME, Franze-Fernandez MT. 1996. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220:223-226.
24. Lundkvist Å, Fatouros A, Niklasson B. 1991. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. J Gen Virol 72:2097-2103.
25. Lundkvist Å, Hörling J, Athlin L, Rosén A, Niklasson B. 1993. Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation. J Gen Virol 74:1303-1310.
26. Lundkvist Å, Hukic M, Hörling J, Gilljam M, Nichol S, Niklasson B. 1997a. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 53:51-59.
27. Lundkvist Å, Cheng Y, Brus Sjölander K, Niklasson B, Vaheri A, Plyusnin A. 1997b. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment. J Virol 71:9515-9523.
28. Lundkvist Å, Niklasson B. 1992. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch Virol 126:93-105.
29. Lundkvist Å, Niklasson B. 1994. Haemorrhagic fever with renal syndrome and other hantavirus infections. Rev Med Virol 4:177-184.
30. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
31. Nichol ST, Ksiazek TG, Rollin PE, Peters CJ. 1996. Hantavirus pulmonary syndrome and newly described hantaviruses in the United States. In: Elliot R. editor. The Bunyaviridae. New York: Plenum Press. p 269-280.
32. Persson MAA, Caothien RH, Burton DR. 1991. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc Natl Acad Sci USA 88:2432-2436.
33. Plyusnin A, Vapalahti O, Lankinen H, Lehvaslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist A, Brummer-Korvenkontio M, Gavrilovskaya I, Vaheri A. 1994. Tula virus: a newly detected hantavirus carried by European common voles. J Virol 68:7833-7839.
34. Plyusnin A, Vapalahti O, Vaheri A. 1996. Hantaviruses: genome structure, expression and evolution. J Gen Virol 77:2677-2687.
35. Salonen E-M, Parren PWHI, Graus YF, Lundkvist Å, Fisicaro P, Vapalahti O, Kallio-Kokko H, Vaheri A, Burton DR. 1998. Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics. J Gen Virol 79:659-665.
36. Samuelsson A, Chiodi F, Öhman P, Putkonen P, Norrby E, Persson MAA. 1995. Chimeric macaque/human Fab molecules neutralize Simian Immunodeficiency Virus. Virology 207:495-502.
37. Schmaljohn A, Li D, Negley D, Bressler D, Turell M, Korch G, Ascher M, Schmaljohn C. 1995. Isolation and initial characterization of a newfound hantavirus from California. Virology 206:963-972.
38. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. 1990. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64:3162-3170.
39. Schmaljohn CS. 1996. Molecular biology of hantaviruses. In: Elliott R, editor. The Bunyaviridae. New York: Plenum Press. p 63-90.
40. Vapalahti O, Kallio-Kokko H, Salonen E-M, Brummer-Korvenkontio M, Vaheri A. 1992. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol 73:829-838.
41. Vapalahti O, Lundkvist Å, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 77:3063-3067.
42. Vapalahti O, Lundkvist Å, Fedorov V, Conroy CJ, Hirvonen S, Plyusnina A, Nemirov K, Fredga K, Cook JA, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A. 1999. Isolation and characterization of a Hantavirus from Lemmus sibericus: evidence for host-switch during hantavirus evolution. J Virol 73:5586-5592.
43. Wyde PR, Moore DK, Hepburn T, Silverman CL, Porter TG, Gross M, Taylor G, Demuth SG, Dillon SB. 1995. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats. Pediatr Res 38: 543-550.
44. Zhang XK, Takashima I, Hashimoto N. 1989. Characteristics of passive immunity against hantavirus infection in rats. Arch Virol 105:235-246.